TVK.TO vs. NVO
TVK.TO (TerraVest Industries Inc.) and NVO (Novo Nordisk A/S) are both stocks. TVK.TO operates in Oil & Gas Equipment & Services (Energy), while NVO operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, TVK.TO returned 36.20%/yr vs 7.17%/yr for NVO. At a 0.07 correlation, their price movements are largely independent.
Performance
TVK.TO vs. NVO - Performance Comparison
Loading charts...
Different Trading Currencies
TVK.TO is traded in CAD, while NVO is traded in USD. To make them comparable, the NVO values have been converted to CAD using the latest available exchange rates.
Returns By Period
In the year-to-date period, TVK.TO achieves a -33.83% return, which is significantly lower than NVO's -15.04% return. Over the past 10 years, TVK.TO has outperformed NVO with an annualized return of 36.20%, while NVO has yielded a comparatively lower 7.17% annualized return.
TVK.TO
- 1D
- 0.28%
- 1M
- -15.32%
- YTD
- -33.83%
- 6M
- -11.21%
- 1Y
- -34.32%
- 3Y*
- 60.42%
- 5Y*
- 45.38%
- 10Y*
- 36.20%
NVO
- 1D
- -4.25%
- 1M
- -9.11%
- YTD
- -15.04%
- 6M
- -8.51%
- 1Y
- -41.30%
- 3Y*
- -16.35%
- 5Y*
- 4.69%
- 10Y*
- 7.17%
TVK.TO vs. NVO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
TVK.TO TerraVest Industries Inc. | -33.83% | 47.85% | 154.61% | 62.88% | 2.14% | 75.27% | 26.32% | 31.99% | 13.03% | 9.55% |
NVO Novo Nordisk A/S | -15.04% | -41.99% | -8.81% | 51.16% | 30.43% | 63.44% | 20.41% | 23.40% | -5.66% | 42.56% |
Correlation
The correlation between TVK.TO and NVO is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.11 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.14 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.09 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.09 |
Correlation (All Time) Calculated using the full available price history since Nov 8, 2012 | 0.07 |
Fundamentals
TVK.TO:
CA$2.41B
NVO:
$182.49B
TVK.TO:
CA$3.35
NVO:
$27.42
TVK.TO:
32.46
NVO:
1.50
TVK.TO:
1.47
NVO:
0.06
TVK.TO:
1.41
NVO:
0.56
TVK.TO:
3.18
NVO:
0.90
TVK.TO:
CA$1.68B
NVO:
$327.80B
TVK.TO:
CA$381.90M
NVO:
$268.30B
TVK.TO:
CA$331.92M
NVO:
$181.54B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TVK.TO vs. NVO — Risk / Return Rank
TVK.TO
NVO
TVK.TO vs. NVO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for TerraVest Industries Inc. (TVK.TO) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| TVK.TO | NVO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.18 | ||
| Sortino ratioReturn per unit of downside risk | +0.38 | ||
| Omega ratioGain probability vs. loss probability | 0.91 | 0.86 | +0.05 |
| Calmar ratioReturn relative to maximum drawdown | -0.91 | -0.76 | -0.15 |
| Martin ratioReturn relative to average drawdown | -1.88 | -1.13 | -0.75 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| TVK.TO | NVO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.62 | -0.80 | +0.18 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 1.13 | 0.12 | +1.01 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 1.02 | 0.22 | +0.80 |
Sharpe Ratio (All Time)Calculated using the full available price history | 1.05 | 0.56 | +0.50 |
Drawdowns
TVK.TO vs. NVO - Drawdown Comparison
The maximum TVK.TO drawdown since its inception was -41.58%, smaller than the maximum NVO drawdown of -74.34%. Use the drawdown chart below to compare losses from any high point for TVK.TO and NVO.
Loading charts...
Drawdown Indicators
| TVK.TO | NVO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -41.58% | -74.34% | +32.76% |
Max Drawdown (1Y)Largest decline over 1 year | -37.79% | -54.42% | +16.63% |
Max Drawdown (3Y)Largest decline over 3 years | -37.79% | -74.34% | +36.55% |
Max Drawdown (5Y)Largest decline over 5 years | -37.79% | -74.34% | +36.55% |
Max Drawdown (10Y)Largest decline over 10 years | -41.58% | -74.34% | +32.76% |
Current DrawdownCurrent decline from peak | -37.62% | -69.57% | +31.95% |
Average DrawdownAverage peak-to-trough decline | -6.76% | -12.21% | +5.45% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 18.29% | 36.65% | -18.36% |
Volatility
TVK.TO vs. NVO - Volatility Comparison
TerraVest Industries Inc. (TVK.TO) has a higher volatility of 41.93% compared to Novo Nordisk A/S (NVO) at 9.77%. This indicates that TVK.TO's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TVK.TO | NVO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 41.93% | 9.77% | +32.16% |
Volatility (6M)Calculated over the trailing 6-month period | 54.31% | 38.41% | +15.90% |
Volatility (1Y)Calculated over the trailing 1-year period | 55.63% | 51.75% | +3.88% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 40.39% | 38.52% | +1.87% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 35.80% | 33.01% | +2.79% |
Dividends
TVK.TO vs. NVO - Dividend Comparison
TVK.TO's dividend yield for the trailing twelve months is around 0.69%, less than NVO's 4.39% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NVO Novo Nordisk A/S | 4.39% | 3.31% | 1.68% | 1.00% | 1.20% | 1.35% | 1.87% | 2.14% | 1.45% | 1.52% | 2.87% | 0.92% |
TVK.TO TerraVest Industries Inc. | 0.69% | 0.44% | 0.56% | 1.19% | 1.54% | 1.46% | 2.50% | 3.08% | 3.94% | 4.28% | 4.49% | 7.04% |
Financials
TVK.TO vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between TerraVest Industries Inc. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
TVK.TO vs. NVO - Profitability Comparison
TVK.TO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, TerraVest Industries Inc. reported a gross profit of 90.64M and revenue of 442.57M. Therefore, the gross margin over that period was 20.5%.
NVO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.
TVK.TO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, TerraVest Industries Inc. reported an operating income of 34.19M and revenue of 442.57M, resulting in an operating margin of 7.7%.
NVO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.
TVK.TO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, TerraVest Industries Inc. reported a net income of 10.04M and revenue of 442.57M, resulting in a net margin of 2.3%.
NVO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.
Frequently Asked Questions
TVK.TO and NVO have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for TVK.TO and NVO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer